Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan).

Source:http://linkedlifedata.com/resource/pubmed/id/9384474

Download in:

View as

General Info

PMID
9384474